Quick Answer
CLOVER HEALTH INVESTMENTS, CORP. /DE reported Diluted EPS of $0.44 per share (loss) for fiscal year 2023.
CLOVER HEALTH INVESTMENTS, CORP. /DE Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2023 | -$0.44 | +38.0% |
| 2022 | -$0.71 | +50.0% |
| 2021 | -$1.42 | +7.8% |
| 2020 | -$1.54 | +62.8% |
| 2019 | -$4.14 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2023 | -$0.09 | +43.8% | -50.0% |
| June 30, 2023 | -$0.06 | +72.7% | +60.0% |
| March 31, 2023 | -$0.15 | +6.3% | +6.3% |
| September 30, 2022 | -$0.16 | -100.0% | +27.3% |
| June 30, 2022 | -$0.22 | +71.8% | -37.5% |
| March 31, 2022 | -$0.16 | -23.1% | -100.0% |
| September 30, 2021 | -$0.08 | -500.0% | +89.7% |
| June 30, 2021 | -$0.78 | -7900.0% | -500.0% |
- CLOVER HEALTH INVESTMENTS, CORP. /DE showed an increase of +38.0% in Diluted EPS compared to the prior fiscal year.
- Over the 2019–2023 period, CLOVER HEALTH INVESTMENTS, CORP. /DE’s diluted eps has grown by 89.4% (from $4.14 per share (loss) to $0.44 per share (loss)).
- The most recent figure is from CLOVER HEALTH INVESTMENTS, CORP. /DE’s fiscal year 2023 report (Form 10-K), filed with the SEC on March 14, 2024.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: